VanEck Biotech ETF (NASDAQ:BBH) Stock Price Down 1.2% – Here’s Why

VanEck Biotech ETF (NASDAQ:BBH)’s share price was down 1.2% during mid-day trading on Monday . The company traded as low as $185.74 and last traded at $185.74. Approximately 3,478 shares changed hands during trading, a decline of 21% from the average daily volume of 4,399 shares. The stock had previously closed at $188.00.

VanEck Biotech ETF Trading Down 2.4%

The business’s 50-day simple moving average is $186.95 and its 200-day simple moving average is $190.73.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Empowered Funds LLC bought a new position in shares of VanEck Biotech ETF in the 4th quarter worth $38,000. Flagship Harbor Advisors LLC bought a new position in VanEck Biotech ETF during the fourth quarter worth about $47,000. Allworth Financial LP boosted its holdings in VanEck Biotech ETF by 255.0% during the fourth quarter. Allworth Financial LP now owns 426 shares of the company’s stock worth $81,000 after buying an additional 306 shares during the last quarter. Fifth Third Bancorp bought a new position in VanEck Biotech ETF during the first quarter worth about $127,000. Finally, Huntington National Bank bought a new stake in shares of VanEck Biotech ETF in the 4th quarter valued at about $132,000. 32.05% of the stock is currently owned by institutional investors.

About VanEck Biotech ETF

The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.